Media coverage
24
Media coverage
Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet Business Wire Country/Territory United States Date 22/08/22 URL www.businesswire.com/news/home/20220822005597/en/Geron-Announces-First-Patient-Dosed-in-IMproveMF-Phase-1-Combination-Study-in-Frontline-Myelofibrosis/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet Morningstar.com Country/Territory United States Date 22/08/22 URL https://www.morningstar.com/news/business-wire/20220822005597/geron-announces-first-patient-dosed-in-improvemf-phase-1-combination-study-in-frontline-myelofibrosis Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis; - Preclinical data showed synergistic and additive effects of combination imetelstat and ruxolitinib - Study intended to explore potential for disease m Media name/outlet Business Wire Country/Territory United States Date 22/08/22 Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet Street Insider Country/Territory United States Date 22/08/22 URL https://www.streetinsider.com/Business+Wire/Geron+Announces+First+Patient+Dosed+in+IMproveMF+Phase+1+Combination+Study+in+Frontline+Myelofibrosis/20495065.html Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet BioSpace Country/Territory United States Date 22/08/22 URL https://www.biospace.com/article/releases/geron-announces-first-patient-dosed-in-improvemf-phase-1-combination-study-in-frontline-myelofibrosis/?s=105 Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet Yahoo! News Country/Territory United States Date 22/08/22 URL https://www.yahoo.com/now/geron-announces-first-patient-dosed-201500975.html Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet Yahoo! Finanzas Country/Territory United States Date 22/08/22 URL https://es-us.finanzas.yahoo.com/news/geron-announces-first-patient-dosed-201500975.html Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet ADVFN UK Country/Territory United Kingdom Date 22/08/22 URL https://uk.advfn.com/stock-market/NASDAQ/GERN/share-news/Geron-Announces-First-Patient-Dosed-in-IMproveMF-P/88890532 Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet Yahoo! Finance Country/Territory United States Date 22/08/22 URL https://finance.yahoo.com/news/geron-announces-first-patient-dosed-201500975.html Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet MarketScreener.com Country/Territory United States Date 22/08/22 URL https://www.marketscreener.com/quote/stock/GERON-CORPORATION-9419/news/Geron-Announces-First-Patient-Dosed-in-IMproveMF-Phase-1-Combination-Study-in-Frontline-Myelofibrosi-41375989/ Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet TD Ameritrade Country/Territory United States Date 22/08/22 URL https://research.tdameritrade.com/grid/public/markets/news/story.asp?fromPage=results&docKey=100-234b7713 Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet ADVFN US Country/Territory United States Date 22/08/22 URL https://www.advfn.com/p.php?pid=nmona&article=88890532 Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet Wallstreet Online Country/Territory Germany Date 22/08/22 URL https://www.wallstreet-online.de/nachricht/15847209-geron-announces-first-patient-dosed-improvemf-phase-1-combination-study-frontline-myelofibrosis Persons John Mascarenhas Title $GERN Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet OTC Dynamics Country/Territory Canada Date 22/08/22 URL https://www.otcdynamics.com/gern-geron-announces-first-patient-dosed-in-improvemf-phase-1-combination-study-in-frontline-myelofibrosis/ Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet Spoke.com Country/Territory United States Date 22/08/22 URL https://www.spoke.com/press_releases/6303e80b00130a4207001b79 Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet Market Newsdesk Country/Territory United States Date 22/08/22 URL https://www.marketnewsdesk.com/index.php/geron-announces-first-patient-dosed-in-improvemf-phase-1-combination-study-in-frontline-myelofibrosis/ Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet Acrofan Date 22/08/22 URL https://us.acrofan.com/detail.php?number=711945 Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet Fort Bend Herald Country/Territory United States Date 22/08/22 URL https://www.fbherald.com/business/geron-announces-first-patient-dosed-in-improvemf-phase-1-combination-study-in-frontline-myelofibrosis/article_b7aac91d-b519-5b25-8576-f29c15ac818e.html Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet Bluefield Daily Telegraph Country/Territory United States Date 22/08/22 URL https://www.bdtonline.com/news/nation_world/geron-announces-first-patient-dosed-in-improvemf-phase-1-combination-study-in-frontline-myelofibrosis/article_392809f2-deb7-5b12-a89b-2a266b699fcf.html Persons John Mascarenhas Title Geron Corp: Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis (Businesswire) Media name/outlet Avanza Bank AB Country/Territory Sweden Date 22/08/22 URL https://www.avanza.se/placera/pressmeddelanden/2022/08/22/geron-corp-geron-announces-first-patient-dosed-in-improvemf-phase-1-combination-study-in-frontline-myelofibrosis.html Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet 1045 TheDan.com Country/Territory United States Date 22/08/22 URL lifestyle.1045thedan.com/story/47137578/geron-announces-first-patient-dosed-in-improvemf-phase-1-combination-study-in-frontline-myelofibrosis Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet HTV 10 - KFOL Country/Territory United States Date 22/08/22 URL www.htv10.tv/story/47137578/geron-announces-first-patient-dosed-in-improvemf-phase-1-combination-study-in-frontline-myelofibrosis Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet VB Profiles Country/Territory United States Date 22/08/22 URL https://www.vbprofiles.com/press_releases/6303e80c5b95f10d11f7fae1 Persons John Mascarenhas Title Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis Media name/outlet MidPlains - News Channel Nebraska Country/Territory United States Date 22/08/22 URL midplains.newschannelnebraska.com/story/47137578/geron-announces-first-patient-dosed-in-improvemf-phase-1-combination-study-in-frontline-myelofibrosis Persons John Mascarenhas